WWMSC
NKTR icon

Wagner Wealth Management (South Carolina)’s Nektar Therapeutics NKTR Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$20K Hold
22
– – 0.01% 345
2018
Q2 		$16K Buy
+22
New +$25.4K 0.01% 339
2017
Q4 		– Hold
0
– – – 604

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s NKTR Position: Q3 2018 in Review

Wagner Wealth Management (South Carolina) held its Nektar Therapeutics (NKTR) position steady in Q3 2018 at 22 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #345.

Wagner Wealth Management (South Carolina) first reported a position in NKTR in Q2 2018 and has held it in 2 quarters since. 389 funds tracked by Wall St. Rank hold NKTR as of Q3 2018.

  • Wagner Wealth Management (South Carolina) held 22 shares of Nektar Therapeutics worth $20K as of Q3 2018.
  • Wagner Wealth Management (South Carolina) left its Nektar Therapeutics share count unchanged in Q3 2018.
  • Nektar Therapeutics made up 0.01% of Wagner Wealth Management (South Carolina)'s portfolio in Q3 2018, its #345 holding.
  • Wagner Wealth Management (South Carolina) first reported a position in Nektar Therapeutics in Q2 2018 and has held it in 2 quarters since.
  • 389 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q3 2018, filed 5 Nov 2018.